AXP vs TECH · P/E 20, rev $41.30B vs P/E 65, rev $1.22B
American Express Company (AXP) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AXP revenue for 2025-12-31 was $41.30B. Net income was $10.83B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AXP and TECH stock pages for the full models.
Not investment advice.